Drug Profile
Diclofenac/eperisone - Eisai
Alternative Names: Eperisone/diclofenac - Eisai; Eprisan D SRLatest Information Update: 27 Jun 2019
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class Muscle relaxants; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Piperidines; Propiophenones; Small molecules
- Mechanism of Action Calcium channel antagonists; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Back pain
Most Recent Events
- 27 Jun 2019 Chemical structure information added
- 30 Sep 2011 Eisai completes a phase III trial in Back pain in India (NCT01300312; CTRI/2010/091/002934)
- 28 Feb 2011 Phase-III clinical trials in Back pain in India (PO)